Company intelligence
EORTC - European Organisation for Research and Treatment of Cancer
The Future of Cancer Therapy
About EORTC - European Organisation for Research and Treatment of Cancer
The European Organisation for Research and Treatment of Cancer (EORTC) is a non-governmental, non-profit organisation, which unites clinical cancer research experts, throughout Europe, to define better treatments for cancer patients to prolong survival and improve quality of life. Spanning from translational to large, prospective, multi-centre, phase III clinical trials that evaluate new therapies and treatment strategies as well as patient quality of life, its activities are coordinated from EORTC Headquarters, a unique international clinical research infrastructure, based in Brussels, Belgium. For further information, please visit the EORTC website: www.eortc.org
Verified activity
Signals from EORTC - European Organisation for Research and Treatment of Cancer
7 published signals
Presence & Recognition
EORTC - European Organisation for Research and Treatment of Cancer is hosting the World Cancer Research Day International Event on 23 September in Brussels.
Reported by EORTC - European Organisation for Research and Treatment of Cancer
Presence & Recognition
EORTC - European Organisation for Research and Treatment of Cancer honored the memory of founding member Prof. Neil Aaronson, who played a defining role in shaping patient-centred cancer research and health-related quality of life research.
Reported by EORTC - European Organisation for Research and Treatment of Cancer
Research & Knowledge
EORTC - European Organisation for Research and Treatment of Cancer announced that the 1,000th patient has been enrolled in the ReCare cohort of the EORTC-ESTRO E²-RADIatE platform.
Reported by EORTC - European Organisation for Research and Treatment of Cancer
Research & Knowledge
EORTC - European Organisation for Research and Treatment of Cancer published a new analysis from the EORTC 1419 (ETERNITY) study showing that 78% of long-term survivors of glioblastoma, IDH-wildtype and astrocytoma, IDH-mutant, CNS WHO grade 4 experience neurocognitive impairment.
Reported by EORTC - European Organisation for Research and Treatment of Cancer
Research & Knowledge
EORTC - European Organisation for Research and Treatment of Cancer published a new perspective from the EORTC Older Adult Council and the EORTC Quality of Life Group in the European Journal of Cancer highlighting the importance of integrating patient preferences into cancer clinical trials.
Reported by EORTC - European Organisation for Research and Treatment of Cancer
Presence & Recognition
EORTC - European Organisation for Research and Treatment of Cancer presented a Spotlight Poster at the ISPE Annual 2026 conference in Milan highlighting research on uncertainties in regulatory decision-making for innovative anticancer medicines.
Reported by EORTC - European Organisation for Research and Treatment of Cancer
People
EORTC - European Organisation for Research and Treatment of Cancer was informed that Dr Vaseeharan Sathiyamoorthy passed away suddenly on 30 August 2026.
Reported by EORTC - European Organisation for Research and Treatment of Cancer